Insmed Incorporated

LSE:0JAV Stock Report

Market Cap: US$12.0b

Insmed Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

LSE:0JAV Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
14 May 25SellUS$325,673Michael SmithIndividual4,816US$67.81
14 May 25SellUS$633,654Roger AdsettIndividual9,407US$67.81
14 May 25SellUS$708,681Sara BonsteinIndividual10,504US$67.81
14 May 25SellUS$1,415,573William LewisIndividual21,213US$67.70
14 May 25SellUS$420,076S. SchaefferIndividual6,235US$67.81
14 May 25SellUS$684,570Martina FlammerIndividual10,152US$67.81
07 Feb 25SellUS$3,697,402Roger AdsettIndividual45,705US$80.90
07 Feb 25SellUS$2,678,925Martina FlammerIndividual33,115US$80.90
07 Feb 25SellUS$789John WiseIndividual10US$78.91
06 Feb 25SellUS$1,670,585Michael SmithIndividual20,650US$80.90
06 Feb 25SellUS$639,919John WiseIndividual7,910US$80.90
06 Feb 25SellUS$6,419,415William LewisIndividual79,350US$80.90
06 Feb 25SellUS$1,901,150S. SchaefferIndividual23,500US$80.90
06 Feb 25SellUS$2,296,751Sara BonsteinIndividual28,390US$80.90
10 Jan 25SellUS$242,816Michael SmithIndividual3,689US$66.21
10 Jan 25SellUS$995,012William LewisIndividual15,195US$66.02
10 Jan 25SellUS$236,274John WiseIndividual3,587US$66.21
10 Jan 25SellUS$312,260S. SchaefferIndividual4,770US$65.88
10 Jan 25SellUS$420,381Martina FlammerIndividual6,417US$66.16
10 Jan 25SellUS$368,472Roger AdsettIndividual5,624US$66.10
10 Jan 25SellUS$392,602Sara BonsteinIndividual6,000US$66.05
12 Aug 24SellUS$686,408S. SchaefferIndividual9,469US$72.49
28 May 24SellUS$78,418John WiseIndividual1,602US$48.95

Insider Trading Volume

Insider Buying: 0JAV insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 0JAV?
Owner TypeNumber of SharesOwnership Percentage
State or Government00%
Individual Insiders1,728,1180.849%
Hedge Funds15,397,9757.57%
Institutions186,328,94591.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 22.6%.

Top Shareholders

Top 25 shareholders own 71.8% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10%
The Vanguard Group, Inc.
18,268,122US$1.2b0.27%0.02%
8.81%
BlackRock, Inc.
16,048,882US$1.1b0.1%0.02%
8.45%
Darwin Global Management Limited
15,397,975US$1.0b18.8%77.92%
7.91%
T. Rowe Price Group, Inc.
14,400,489US$950.7m-1.95%0.09%
3.95%
Capital Research and Management Company
7,198,485US$475.2m1.14%0.02%
3.16%
JP Morgan Asset Management
5,757,589US$380.1m89.9%0.04%
3.16%
State Street Global Advisors, Inc.
5,747,293US$379.4m-5.88%0.01%
2.95%
Baker Bros. Advisors LP
5,380,626US$355.2m7.47%2.96%
2.35%
Geode Capital Management, LLC
4,288,735US$283.1m4.93%0.02%
1.89%
Adage Capital Management, L.P.
3,446,944US$227.6m109%0.41%
1.85%
FMR LLC
3,363,058US$222.0m-30.3%0.01%
1.77%
Artisan Partners Limited Partnership
3,217,268US$212.4m2.91%0.15%
1.66%
RTW Investments, LP
3,014,558US$199.0m0%3.07%
1.62%
Columbia Management Investment Advisers, LLC
2,951,622US$194.9m3.56%0.05%
1.33%
AllianceBernstein L.P.
2,423,513US$160.0m2.54%0.05%
1.31%
Fidelity International Ltd
2,390,201US$157.8m-9.4%0.06%
1.3%
Macquarie Investment Management Business Trust
2,362,105US$155.9m2.12%0.2%
1.27%
William Blair Investment Management, LLC
2,313,217US$152.7m-4.94%0.19%
1.11%
Holocene Advisors, LP
2,026,422US$133.8m195%0.38%
1.11%
Pictet Asset Management Limited
2,013,329US$132.9m2.74%0.09%
1.01%
Norges Bank Investment Management
1,833,810US$121.1m0%0.01%
1%
ClearBridge Investments, LLC
1,828,728US$120.7m-2.65%0.1%
0.96%
Principal Global Investors, LLC
1,755,373US$115.9m-3.59%0.06%
0.92%
Northern Trust Global Investments
1,683,838US$111.2m-3.82%0.02%
0.91%
Franklin Resources, Inc.
1,656,368US$109.4m-3.36%0.04%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/22 22:01
End of Day Share Price 2025/05/22 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Insmed Incorporated is covered by 34 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Neena Bitritto-GargBaird
Anita DushyanthBerenberg
Jason ZemanskyBofA Global Research